Novanta Posts Record Margin as Shares Fall Sharply
Revenue up 23 percent, a record 26.3 percent EBITDA margin, bookings up 29 percent, and a 15 percent stock drop: the quarter and the market disagree.
Novanta reported a record 26.3 percent EBITDA margin for the third quarter while its shares fell 15.26 percent.
Novanta posted record margins and 23 percent revenue growth on Tuesday, and its shares fell 15 percent anyway.
Novanta reported third-quarter 2026 revenue of $305 million, up 23.1 percent, with adjusted EBITDA of $80.3 million at a record 26.3 percent margin, while its shares fell 15.26 percent on the day of the report. [The Motley Fool — Novanta (NOVT) Q3 2026 earnings call transcript (November 10, 2026)]
Under the headline figures: organic growth of 9.9 percent, adjusted earnings of $1.05 per share, up 21 percent, bookings of $393.5 million, up 29 percent, and a backlog of $543 million with the core backlog up 14 percent. Operating cash flow reached $155.9 million for the year to date, nearly three times the prior year. The Riverpoint Medical acquisition, closed in July, contributed $33 million in its first two months and pushed medical markets to 53 percent of total sales, the company's deliberate shift toward less cyclical work. Net debt stands at $689.4 million, 2.2 times earnings. [The Motley Fool — Novanta (NOVT) Q3 2026 earnings call transcript (November 10, 2026)]
The guidance explains part of the market's mood, arithmetically at least. Fourth-quarter revenue is guided at $306 million to $312 million, roughly flat against the third quarter, and adjusted earnings at $0.91 to $0.96 per share, a step down from the $1.05 just reported. Full-year adjusted EBITDA guidance of $274 million to $277 million implies growth of 24 to 25 percent. A record quarter followed by a guided step-down is a familiar recipe for a falling stock, and Novanta's fell 15.26 percent on the day. Which number history keeps, the record margin or the lower guide, depends on whether the fourth quarter lands as a pause or a turn. [The Motley Fool — Novanta (NOVT) Q3 2026 earnings call transcript (November 10, 2026)]
The conversation.
Loading comments…

A little more perspective.
Reading is free. Verified members can comment and reply for $2 a month.